Advertisement

Journal of Autism and Developmental Disorders

, Volume 45, Issue 4, pp 1062–1069 | Cite as

Differences in Autism Spectrum Disorders Incidence by Sub-Populations in Israel 1992–2009: A Total Population Study

  • Raanan RazEmail author
  • Marc G. Weisskopf
  • Michael Davidovitch
  • Ofir Pinto
  • Hagai Levine
Original Paper

Abstract

We analyzed data from the Israeli National Insurance Institute (NII). Autism Spectrum Disorder (ASD) incidence was calculated for all children born in Israel 1992–2009, and by population groups. Overall, 9,109 ASD cases among 2,431,649 children were identified. ASD cumulative incidence by age 8 years increased 10-fold during 2000–2011, from 0.49 % to 0.49 %, while other child disabilities in NII increased only 1.65-fold. There was a consistent increase in ASD incidence with advancing birth cohorts born 1992–2004, stabilizing among those born 2005–2009. ASD rates among Israeli Arabs were substantially lower, and increased about 10 years later than the general population. The findings suggest a role for ASD awareness, accessing of the government benefit, or the way the concept of ASD is perceived.

Keywords

Autism Incidence Prevalence Israel Sub-populations 

Notes

Acknowledgments

This study was supported by the Environment and Health Fund (EHF, Israel), the Harvard-NIEHS center (P30-ES000002), and Mr. James Crystal in honor of Mrs. Lillian Yaros. We wish to thank Daniel Gottlieb, Rivka Prior, Alex Gealia, Alina Milkin and Meira Schwartz from the Israeli National Insurance Institute for insightful discussions and assistance in data collection.

Conflict of interest

Drs. Raz, Weisskopf and Levine, and Mr. Pinto report no other biomedical financial interests or potential conflicts of interest.

Supplementary material

10803_2014_2262_MOESM1_ESM.pdf (400 kb)
Supplementary material 1 (PDF 399 kb)
10803_2014_2262_MOESM2_ESM.pdf (195 kb)
Supplementary material 2 (PDF 195 kb)

References

  1. Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., et al. (2006). Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: The Special Needs and Autism Project (SNAP). Lancet, 368(9531), 210–215. doi: 10.1016/S0140-6736(06)69041-7.CrossRefPubMedGoogle Scholar
  2. Croen, L. A, Grether, J. K., Hoogstrate, J., & Selvin, S. (2002). The changing prevalence of autism in California. Journal of Autism and Developmental Disorders, 32(3), 207–15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12757365
  3. Davidovitch, M., Hemo, B., Manning-Courtney, P., & Fombonne, E. (2013). Prevalence and incidence of autism spectrum disorder in an Israeli population. Journal of Autism and Developmental Disorders, 43(4), 785–793. doi: 10.1007/s10803-012-1611-z.CrossRefPubMedGoogle Scholar
  4. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators., & Centers for Disease Control and Prevention. (2014). Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2010. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002), 63 Suppl 2(2), 1–21. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24670961
  5. Fombonne, E. (2001). Is there an epidemic of autism? Pediatrics, 107(2), 411–412. Retrieved from http://pediatrics.aappublications.org/content/107/2/411.short
  6. Fombonne, E. (2003). The prevalence of autism. JAMA, 289(1), 87–89. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22836322
  7. Fombonne, E. (2009). Commentary: on King and Bearman. International Journal of Epidemiol, 38(5), 1241–2; author reply 1243–4. doi: 10.1093/ije/dyp259
  8. French, L. R., Bertone, A., Hyde, K. L., & Fombonne, E. (2013). Epidemiology of autism spectrum disorders. In The neuroscience of autism spectrum disorders (pp. 3–24). Elsevier. doi: 10.1016/B978-0-12-391924-3.00001-6
  9. Gal, G., Abiri, L., Reichenberg, A., Gabis, L., & Gross, R. (2012). Time trends in reported autism spectrum disorders in Israel, 1986–2005. Journal of Autism and Developmental Disorders, 42(3), 428–431. doi: 10.1007/s10803-011-1252-7.CrossRefPubMedGoogle Scholar
  10. Gal, G., & Gross, R. (2010). Time trends in autism. The Israel Medical Association Journal, 12(11), 711–712. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23959427
  11. Gillberg, C., Cederlund, M., Lamberg, K., & Zeijlon, L. (2006). Brief report: “The autism epidemic”. The registered prevalence of autism in a Swedish urban area. Journal of Autism and Developmental Disorders, 36(3), 429–435. doi: 10.1007/s10803-006-0081-6.CrossRefPubMedGoogle Scholar
  12. Gurney, J. G., Fritz, M. S., Ness, K. K., Sievers, P., Newschaffer, C. J., & Shapiro, E. G. (2003). Analysis of prevalence trends of autism spectrum disorder in Minnesota. Archives of Pediatrics and Adolescent Medicine, 157(7), 622–627. doi: 10.1001/archpedi.157.7.622.CrossRefPubMedGoogle Scholar
  13. Hertz-Picciotto, I. (2009). Commentary: Diagnostic change and the increased prevalence of autism. International Journal of Epidemiology, 38(5), 1239–1241; author reply 1243–4. doi: 10.1093/ije/dyp258
  14. Hertz-Picciotto, I., & Delwiche, L. (2009). The rise in autism and the role of age at diagnosis. Epidemiology, 20(1), 84–90. doi: 10.1097/EDE.0b013e3181902d15.CrossRefPubMedCentralPubMedGoogle Scholar
  15. Hoffman, K., Kalkbrenner, A. E., Vieira, V. M., & Daniels, J. L. (2012). The spatial distribution of known predictors of autism spectrum disorders impacts geographic variability in prevalence in central North Carolina. Environ Health, 11(1), 80. doi: 10.1186/1476-069X-11-80.CrossRefPubMedCentralPubMedGoogle Scholar
  16. Honda, H., Shimizu, Y., & Rutter, M. (2005). No effect of MMR withdrawal on the incidence of autism: A total population study. Journal of Child Psychology and Psychiatry and Allied Disciplines, 46(6), 572–579. doi: 10.1111/j.1469-7610.2005.01425.x.CrossRefGoogle Scholar
  17. Principal Investigators, Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008, & Centers for Disease Control and Prevention. (2012). Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002), 61(3), 1–19. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22456193
  18. Isaksen, J., Diseth, T. H., Schjølberg, S., & Skjeldal, O. H. (2012). Observed prevalence of autism spectrum disorders in two Norwegian counties. European Journal of Paediatric Neurology, 16(6), 592–598. doi: 10.1016/j.ejpn.2012.01.014.CrossRefPubMedGoogle Scholar
  19. Isaksen, J., Diseth, T. H., Schjølberg, S., & Skjeldal, O. H. (2013). Autism spectrum disorders—Are they really epidemic? European Journal of Paediatric Neurology, 17(4), 327–333. doi: 10.1016/j.ejpn.2013.03.003.CrossRefPubMedGoogle Scholar
  20. Israeli, A. (2007). Diagnosis of children suffering from autism PDD (the autism spectrum). Ministry of Health, Israel. Retrieved from http://www.health.gov.il/hozer/mk13_2007.pdf
  21. Kamer, A., Zohar, A. H., Youngmann, R., Diamond, G. W., Inbar, D., & Senecky, Y. (2004). A prevalence estimate of pervasive developmental disorder among immigrants to Israel and Israeli natives—A file review study. Social Psychiatry and Psychiatric Epidemiology, 39(2), 141–145. doi: 10.1007/s00127-004-0696-x.CrossRefPubMedGoogle Scholar
  22. Kawamura, Y., Takahashi, O., & Ishii, T. (2008). Reevaluating the incidence of pervasive developmental disorders: Impact of elevated rates of detection through implementation of an integrated system of screening in Toyota, Japan. Psychiatry Clin Neurosciences, 62(2), 152–159. doi: 10.1111/j.1440-1819.2008.01748.x.CrossRefGoogle Scholar
  23. Keyes, K. M., Susser, E., Cheslack-Postava, K., Fountain, C., Liu, K., & Bearman, P. S. (2012). Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California. International Journal of Epidemiology, 41(2), 495–503. doi: 10.1093/ije/dyr193.CrossRefPubMedCentralPubMedGoogle Scholar
  24. Kim, Y. S., Leventhal, B. L., Koh, Y., Laska, E., Lim, E., Kim, S., et al. (2011). Prevalence of autism spectrum disorders in a total population sample. American Journal of Psychiatry, 168, 904–912.CrossRefPubMedGoogle Scholar
  25. King, M., & Bearman, P. (2009). Diagnostic change and the increased prevalence of autism. International Journal of Epidemiology, 38(5), 1224–1234. doi: 10.1093/ije/dyp261.CrossRefPubMedCentralPubMedGoogle Scholar
  26. Lazoff, T., Zhong, L., Piperni, T., & Fombonne, E. (2010). Prevalence of pervasive developmental disorders among children at the English Montreal School Board. Canadian journal of psychiatry. Revue canadienne de Psychiatrie, 55(11), 715–20. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21070699
  27. Leonard, H., Glasson, E., Nassar, N., Whitehouse, A., Bebbington, A., Bourke, J., et al. (2011). Autism and intellectual disability are differentially related to sociodemographic background at birth. PLoS ONE, 6(3), e17875. doi: 10.1371/journal.pone.0017875.CrossRefPubMedCentralPubMedGoogle Scholar
  28. Manor-Binyamini, I. (2012). Parental coping with developmental disorders in adolescents within the ultraorthodox Jewish community in Israel. Journal of Autism and Developmental Disorders, 42(5), 815–826. doi: 10.1007/s10803-011-1313-y.CrossRefPubMedGoogle Scholar
  29. Nassar, N., Dixon, G., Bourke, J., Bower, C., Glasson, E., de Klerk, N., et al. (2009). Autism spectrum disorders in young children: Effect of changes in diagnostic practices. International Journal of Epidemiology, 38(5), 1245–1254. doi: 10.1093/ije/dyp260.CrossRefPubMedGoogle Scholar
  30. Oliveira, G., Ataíde, A., Marques, C., Miguel, T. S., Coutinho, A. M., Mota-Vieira, L., et al. (2007). Epidemiology of autism spectrum disorder in Portugal: Prevalence, clinical characterization, and medical conditions. Developmental Medicine and Child Neurology, 49(10), 726–733. doi: 10.1111/j.1469-8749.2007.00726.x.CrossRefPubMedGoogle Scholar
  31. Pettygrove, S., Pinborough-Zimmerman, J., John Meaney, F., Van Naarden Braun, K., Nicholas, J., Miller, L., et al. (2012). Predictors of ascertainment of autism spectrum disorders across nine US communities. Journal of Autism and Developmental Disorders,. doi: 10.1007/s10803-012-1732-4.Google Scholar
  32. Rosen, B., Samuel, H., & Merkur, E. S. (2009). Israel: Health system review. Health Systems in Transition, 11(2), 1–226.Google Scholar
  33. Saemundsen, E., Magnússon, P., Georgsdóttir, I., Egilsson, E., & Rafnsson, V. (2013). Prevalence of autism spectrum disorders in an Icelandic birth cohort. BMJ Open, 3(6), 1–6. doi: 10.1136/bmjopen-2013-002748.CrossRefGoogle Scholar
  34. Schechter, R., & Grether, J. K. (2008). Continuing increases in autism reported to California’s developmental services system. Archives of Pediatrics and Adolescent Medicine, 65(1), 19–24.Google Scholar
  35. Schieve, L. A., Rice, C., Yeargin-Allsopp, M., Boyle, C. A., Kogan, M. D., Drews, C., et al. (2012). Parent-reported prevalence of autism spectrum disorders in US-born children: An assessment of changes within birth cohorts from the 2003 to the 2007 National Survey of Children’s Health. Maternal and Child Health Journal, 16(Suppl 1), S151–S157. doi: 10.1007/s10995-012-1004-0.CrossRefPubMedGoogle Scholar
  36. Senecky, Y., Chodick, G., Diamond, G., Lobel, D., Drachman, R., & Inbar, D. (2009). Time trends in reported autistic spectrum disorders in Israel, 1972–2004. The Israel Medical Association Journl, 11(1), 30–33. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19344009
  37. Shaked, M., & Bilu, Y. (2006). Grappling with affliction: autism in the Jewish ultraorthodox community in Israel. Culture, Medicine and Psychiatry, 30(1), 1–27. doi: 10.1007/s11013-006-9006-2.CrossRefPubMedGoogle Scholar
  38. Shattuck, P. T. (2006). The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education. Pediatrics, 117(4), 1028–1037. doi: 10.1542/peds.2005-1516.CrossRefPubMedGoogle Scholar
  39. The National Insurance Institute (Disabled Child—Benefit Rates). (n.d.-a). Retrieved November 19, 2013, from http://www.btl.gov.il/EnglishHomepage/Benefits/Disabledchild/Pages/BenefitRates.aspx
  40. The National Insurance Institute—Appealing a Decision. (n.d.-b). Retrieved November 19, 2013, from http://www.btl.gov.il/EnglishHomepage/Benefits/Disabledchild/Pages/Appealingadecision.aspx
  41. The National Insurance Institute—Benefits. (n.d.-c). Retrieved November 19, 2013, from http://www.btl.gov.il/EnglishHomepage/Benefits/Pages/default.aspx
  42. The National Insurance Institute—Disabled Child. (n.d.-d). Retrieved November 19, 2013, from http://www.btl.gov.il/EnglishHomepage/Benefits/Disabledchild/Pages/default.aspx
  43. The National Insurance Institute—Take up of Rights (Hebrew). (n.d.-e). Retrieved November 19, 2013, from http://www.btl.gov.il/AllRights/Pages/mosdot.aspx
  44. Williams, E., Thomas, K., Sidebotham, H., & Emond, A. (2008). Prevalence and characteristics of autistic spectrum disorders in the ALSPAC cohort. Developmental Medicine and Child Neurology, 50(9), 672–677. doi: 10.1111/j.1469-8749.2008.03042.x.CrossRefPubMedGoogle Scholar
  45. Wing, L., & Potter, D. (2002). The epidemiology of autistic spectrum disorders: Is the prevalence rising? Mental Retardation and Developmental Disabilities Research Reviews, 8(3), 151–161. doi: 10.1002/mrdd.10029.CrossRefPubMedGoogle Scholar
  46. Wood, S. (2012). Package mgcv. Retrieved from http://cran.r-project.org/web/packages/mgcv/index.html
  47. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. JAMA, 289(1), 49–55. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12503976
  48. Zaroff, C. M., & Uhm, S. Y. (2012). Prevalence of autism spectrum disorders and influence of country of measurement and ethnicity. Social Psychiatry and Psychiatric Epidemiology, 47(3), 395–398. doi: 10.1007/s00127-011-0350-3.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Raanan Raz
    • 1
  • Marc G. Weisskopf
    • 2
  • Michael Davidovitch
    • 3
  • Ofir Pinto
    • 4
  • Hagai Levine
    • 5
  1. 1.Department of Environmental HealthHarvard School of Public HealthBostonUSA
  2. 2.Departments of Environmental Health and EpidemiologyHarvard School of Public HealthBostonUSA
  3. 3.Medical Division, Department of Child DevelopmentMaccabi Healthcare ServicesTel AvivIsrael
  4. 4.The National Insurance Institute of IsraelJerusalemIsrael
  5. 5.Braun School of Public Health and Community MedicineHebrew University-HadassahJerusalemIsrael

Personalised recommendations